Abraham Scaria
Seminars
Tuesday 24th March 2026
Panel Discussion: Scaling Clinical Operations to Support Gene Therapies for Larger Populations
9:00 am
- Highlighting the limitations of current small-batch methods in meeting the needs of larger patient populations
- Understanding the unique manufacturing, financial, and regulatory challenges associated with working on common disease indications
- Anticipating the scientific and operational shifts needed to make gene therapy viable for high-prevalence conditions
Tuesday 24th March 2026
Gene Therapy for Dry AMD Using AAV to Improve Durability & Compliance
10:00 am
- Complement Inhibitors clinically validated for treatment of dry AMD
- AAV vectors can potentially transform treatment from monthly injections to a single long-lasting intervention
- Intravitreal delivery using novel AAV capsid
